Vertex Pharmaceuticals Inc. buy Citigroup Inc.
Start price
02.10.25
/
50%
€346.50
Target price
02.10.26
€489.84
Performance (%)
11.40%
Price
01.04.26
€386.00
Summary
This prediction is currently active. The prediction currently has a performance of 11.40%. This prediction currently runs until 02.10.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.956% | -1.956% |
| iShares Core DAX® | 1,60 % | -7,45 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % |
| iShares S&P 500 | -0,39 % | -2,34 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) had its price target raised by analysts at Citigroup Inc. from $550.00 to $575.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€435.00
10.03.26
10.03.26
€503.22
10.03.27
10.03.27
-11.26%
01.04.26
01.04.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€470.80
14.11.24
14.11.24
€545.96
14.11.25
14.11.25
-19.47%
15.11.25
15.11.25